Alan Nafiiev is the CEO and founder of Receptor.AI, where he leads the development of AI-driven platforms for drug discovery. He holds a Ph.D. in Data Science and AI, with expertise spanning small molecules, peptides, and protein-protein interactions. His current work and writing focus on hybrid AI-physics methods and platform-based approaches for scalable, data-driven drug discovery.